Literature DB >> 15670796

The effect of interleukin-1 on cytokine gene expression by human corneal epithelial cells.

Srihari Narayanan1, Adrian Glasser, Ying-Sheng Hu, Alison M McDermott.   

Abstract

The purpose of this study was to characterize the pattern of cytokine gene expression by human corneal epithelial cells (HCEC) in response to interleukin-1 (IL-1). Primary cultured HCEC (P-HCEC) or SV40 transformed HCEC (SV40-HCEC) were treated for 6 hr with serum-free growth-media alone or with recombinant human IL-1beta or IL-1alpha (10 ng ml(-1)). 33P labeled cDNA was generated from total RNA, then hybridized to a human cytokine expression array. An autoradiograph was generated for each experimental condition and results analysed semi-quantitatively. Reverse transcription polymerase chain reaction (RT-PCR) was performed to detect mRNA for IL-8, growth related oncogene-beta (GRO-beta), intercellular adhesion molecule (ICAM)-1 and Ephrin A5. P-HCEC and SV40-HCEC demonstrated comparable cytokine profiles. For P-HCEC (n=2) the expression of 35 genes was upregulated or only detectable following IL-1beta treatment whereas the expression of nine genes was downregulated or undetectable after IL-1beta treatment. In SV40-HCEC (n=3), the expression of 48 genes was upregulated or only detectable following IL-1beta treatment and the expression of 10 genes was downregulated or undetectable after IL-1beta treatment. Some genes that demonstrated increased expression included cadherin-5, ICAM-1, GRO-alpha, GRO-beta, GRO-gamma, Activin A (bA subunit), tumor necrosis factor-alpha, IL-6, and IL-8. Genes that showed decreased expression included the chemokine receptor-CXCR-4, ciliary neurotrophic factor (CNTF), c-kit ligand, Ephrin A5, G-protein coupled receptor RDC-1 and FGF family FGFR2. Bayesian analysis of the SV40-HCEC data (n=3) revealed the expression of 15 genes that were significantly (p<0.05) differentially regulated. Within these 15 genes, the expression of chemokines (GRO-alpha, GRO-beta, IL-8), fibroblast growth factor 13 and the cytokine IL-6 were the most upregulated, while ephrin A5 and chemokine receptor-4 were the most downregulated. IL-1alpha treatment (n=1 P-HCEC; n=1 SV40-HCEC) produced results very similar to IL-1beta treatment. RT-PCR revealed differential regulation of IL-8, GRO-beta, ICAM-1 and ephrin A5 in accordance with gene array data. In conclusion, the data demonstrate that IL-1 treatment of HCEC differentially regulates the expression of other cytokine and related genes, thus adding to the body of evidence that IL-1 is a major mediator of ocular surface inflammatory reactions. Since the expression of a large number of genes can be studied simultaneously, gene array studies such as these offers the advantage of understanding global changes in response to a specific stimulus. Thus our study provides insight in to the ocular surface response in conditions of inflammation and corneal wound healing where the levels of IL-1 are known to be increased.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670796     DOI: 10.1016/j.exer.2004.08.027

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  17 in total

1.  Modulatory effect of whey proteins in some cytokines involved in wound healing in male diabetic albino rats.

Authors:  Bahaa Kenawy Abuel-Hussien Abdel-Salam
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

2.  Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection.

Authors:  N Yawata; K J Selva; Y-C Liu; K P Tan; A W L Lee; J Siak; W Lan; M Vania; A Arundhati; L Tong; J Li; J S Mehta; M Yawata
Journal:  Mucosal Immunol       Date:  2015-06-17       Impact factor: 7.313

3.  EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration.

Authors:  Nihal Kaplan; Anees Fatima; Han Peng; Paul J Bryar; Robert M Lavker; Spiro Getsios
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

4.  Herpes simplex virus-1 infection or Simian virus 40-mediated immortalization of corneal cells causes permanent translocation of NLRP3 to the nuclei.

Authors:  Shu-Long Wang; Ge Zhao; Wei Zhu; Xiao-Meng Dong; Ting Liu; Yuan-Yuan Li; Wen-Gang Song; Yi-Qiang Wang
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

Review 5.  Non-invasive objective and contemporary methods for measuring ocular surface inflammation in soft contact lens wearers - A review.

Authors:  Cecilia Chao; Kathryn Richdale; Isabelle Jalbert; Kim Doung; Moneisha Gokhale
Journal:  Cont Lens Anterior Eye       Date:  2017-06-09       Impact factor: 3.077

Review 6.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

7.  Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration into the cornea.

Authors:  W Michael Stapleton; Shyam S Chaurasia; Fabricio W Medeiros; Rajiv R Mohan; Sunilima Sinha; Steven E Wilson
Journal:  Exp Eye Res       Date:  2008-02-13       Impact factor: 3.467

8.  Changes in Tear Cytokine Concentrations Following Discontinuation of Soft Contact Lenses-A Pilot Study.

Authors:  Cecilia Chao; Blanka Golebiowski; Fiona Stapleton; Kathryn Richdale
Journal:  Eye Contact Lens       Date:  2016-07       Impact factor: 2.018

9.  Acanthamoeba-cytopathic protein induces apoptosis and proinflammatory cytokines in human corneal epithelial cells by cPLA2α activation.

Authors:  Trivendra Tripathi; Ashley Dawn Smith; Mahshid Abdi; Hassan Alizadeh
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-05       Impact factor: 4.799

10.  Different inflammatory responses are associated with Ureaplasma parvum-induced UTI and urolith formation.

Authors:  Leticia Reyes; Mary Reinhard; Mary B Brown
Journal:  BMC Infect Dis       Date:  2009-01-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.